184 related articles for article (PubMed ID: 37558702)
21. The hematopoietic stem cell niche in homeostasis and disease.
Calvi LM; Link DC
Blood; 2015 Nov; 126(22):2443-51. PubMed ID: 26468230
[TBL] [Abstract][Full Text] [Related]
22. [Epithelial stem cell and cancer].
Taipale J
Duodecim; 2004; 120(4):373-5. PubMed ID: 15065454
[No Abstract] [Full Text] [Related]
23. Role of Donor Clonal Hematopoiesis in Allogeneic Hematopoietic Stem-Cell Transplantation.
Frick M; Chan W; Arends CM; Hablesreiter R; Halik A; Heuser M; Michonneau D; Blau O; Hoyer K; Christen F; Galan-Sousa J; Noerenberg D; Wais V; Stadler M; Yoshida K; Schetelig J; Schuler E; Thol F; Clappier E; Christopeit M; Ayuk F; Bornhäuser M; Blau IW; Ogawa S; Zemojtel T; Gerbitz A; Wagner EM; Spriewald BM; Schrezenmeier H; Kuchenbauer F; Kobbe G; Wiesneth M; Koldehoff M; Socié G; Kroeger N; Bullinger L; Thiede C; Damm F
J Clin Oncol; 2019 Feb; 37(5):375-385. PubMed ID: 30403573
[TBL] [Abstract][Full Text] [Related]
24. Modeling of hematologic malignancies by iPS technology.
Arai S; Miyauchi M; Kurokawa M
Exp Hematol; 2015 Aug; 43(8):654-60. PubMed ID: 26135030
[TBL] [Abstract][Full Text] [Related]
25. Clonal diversity in the myeloproliferative neoplasms: independent origins of genetically distinct clones.
Beer PA; Jones AV; Bench AJ; Goday-Fernandez A; Boyd EM; Vaghela KJ; Erber WN; Odeh B; Wright C; McMullin MF; Cullis J; Huntly BJ; Harrison CN; Cross NC; Green AR
Br J Haematol; 2009 Mar; 144(6):904-8. PubMed ID: 19170680
[TBL] [Abstract][Full Text] [Related]
26. Clonal evolution in hematological malignancies and therapeutic implications.
Landau DA; Carter SL; Getz G; Wu CJ
Leukemia; 2014 Jan; 28(1):34-43. PubMed ID: 23979521
[TBL] [Abstract][Full Text] [Related]
27. Retinoic acid, CYP26, and drug resistance in the stem cell niche.
Alonso S; Jones RJ; Ghiaur G
Exp Hematol; 2017 Oct; 54():17-25. PubMed ID: 28754309
[TBL] [Abstract][Full Text] [Related]
28. Matrix metalloproteinases in bone marrow: roles of gelatinases in physiological hematopoiesis and hematopoietic malignancies.
Yu XF; Han ZC
Histol Histopathol; 2006 May; 21(5):519-31. PubMed ID: 16493582
[TBL] [Abstract][Full Text] [Related]
29. Cytological characterization of murine bone marrow and spleen hematopoietic compartments for improved assessment of toxicity in preclinical gene marking models.
Yang M; Büsche G; Ganser A; Li Z
Ann Hematol; 2013 May; 92(5):595-604. PubMed ID: 23307598
[TBL] [Abstract][Full Text] [Related]
30. Regulation of Hematopoietic Stem Cell Fate and Malignancy.
Cho HJ; Lee J; Yoon SR; Lee HG; Jung H
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32640596
[TBL] [Abstract][Full Text] [Related]
31. Microarray Gene Expression Analysis to Evaluate Cell Type Specific Expression of Targets Relevant for Immunotherapy of Hematological Malignancies.
Pont MJ; Honders MW; Kremer AN; van Kooten C; Out C; Hiemstra PS; de Boer HC; Jager MJ; Schmelzer E; Vries RG; Al Hinai AS; Kroes WG; Monajemi R; Goeman JJ; Böhringer S; Marijt WA; Falkenburg JH; Griffioen M
PLoS One; 2016; 11(5):e0155165. PubMed ID: 27171398
[TBL] [Abstract][Full Text] [Related]
32. Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes.
Coombs CC; Zehir A; Devlin SM; Kishtagari A; Syed A; Jonsson P; Hyman DM; Solit DB; Robson ME; Baselga J; Arcila ME; Ladanyi M; Tallman MS; Levine RL; Berger MF
Cell Stem Cell; 2017 Sep; 21(3):374-382.e4. PubMed ID: 28803919
[TBL] [Abstract][Full Text] [Related]
33. Foxm1 haploinsufficiency drives clonal hematopoiesis and promotes a stress-related transition to hematologic malignancy in mice.
Yu C; Sheng Y; Yu F; Ni H; Qiu A; Huang Y; Qian Z
J Clin Invest; 2023 Aug; 133(15):. PubMed ID: 37526082
[TBL] [Abstract][Full Text] [Related]
34. Polycomb complexes in normal and malignant hematopoiesis.
Di Carlo V; Mocavini I; Di Croce L
J Cell Biol; 2019 Jan; 218(1):55-69. PubMed ID: 30341152
[TBL] [Abstract][Full Text] [Related]
35. Research progress on exosomes derived from mesenchymal stem cells in hematological malignancies.
Lyu T; Zhang B; Li M; Jiao X; Song Y
Hematol Oncol; 2021 Apr; 39(2):162-169. PubMed ID: 32869900
[TBL] [Abstract][Full Text] [Related]
36. Clonal hematopoiesis in hematological disorders: Three different scenarios.
Swierczek S; Prchal JT
Exp Hematol; 2020 Mar; 83():57-65. PubMed ID: 32007480
[TBL] [Abstract][Full Text] [Related]
37. Prognostic Impact of Lymphocyte Subpopulations in Peripheral Blood after Hematopoietic Stem Cell Transplantation for Hematologic Malignancies.
Park SH; Park CJ; Park BG; Bae MH; Kim BH; Cho YU; Jang S; Park AJ; Kim DY; Lee JH; Lee JH; Lee KH
Cytometry B Clin Cytom; 2018 Mar; 94(2):270-280. PubMed ID: 28103645
[TBL] [Abstract][Full Text] [Related]
38. Stem cell damage after chemotherapy- can we do better?
Tang J; Zhu N; Rao S; Carlson KS
Best Pract Res Clin Haematol; 2019 Mar; 32(1):31-39. PubMed ID: 30927973
[TBL] [Abstract][Full Text] [Related]
39. The Dual Role of ROS in Hematological Malignancies: Stem Cell Protection and Cancer Cell Metastasis.
Samimi A; Khodayar MJ; Alidadi H; Khodadi E
Stem Cell Rev Rep; 2020 Apr; 16(2):262-275. PubMed ID: 31912368
[TBL] [Abstract][Full Text] [Related]
40. Bone Marrow Micro-Environment in Normal and Deranged Hematopoiesis: Opportunities for Regenerative Medicine and Therapies.
Sarkaria SM; Decker M; Ding L
Bioessays; 2018 Mar; 40(3):. PubMed ID: 29384206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
